Movatterモバイル変換


[0]ホーム

URL:


CN101074480A - Method for crystallizing L-cysteine muriate high-purity crystal - Google Patents

Method for crystallizing L-cysteine muriate high-purity crystal
Download PDF

Info

Publication number
CN101074480A
CN101074480ACN200710027349.4ACN200710027349ACN101074480ACN 101074480 ACN101074480 ACN 101074480ACN 200710027349 ACN200710027349 ACN 200710027349ACN 101074480 ACN101074480 ACN 101074480A
Authority
CN
China
Prior art keywords
cysteine
crystallization
muriate
crystal
halfcystine
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN200710027349.4A
Other languages
Chinese (zh)
Inventor
黄侦凯
陈德苞
张楚杨
赵书煌
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
ZIGUANGGUHAN AMINO ACID CO Ltd SHANTOU
Original Assignee
ZIGUANGGUHAN AMINO ACID CO Ltd SHANTOU
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by ZIGUANGGUHAN AMINO ACID CO Ltd SHANTOUfiledCriticalZIGUANGGUHAN AMINO ACID CO Ltd SHANTOU
Priority to CN200710027349.4ApriorityCriticalpatent/CN101074480A/en
Publication of CN101074480ApublicationCriticalpatent/CN101074480A/en
Pendinglegal-statusCriticalCurrent

Links

Landscapes

Abstract

A method for crystallizing L-beta-mercaptoalanine high-purity crystal is carried out by preparing L-beta-mercaptoalanine cathode electrolytic bath liquid by electrolyzing L-cystine, decompress concentrating for electrolytic bath liquid at 70-80 degree, reaching L-beta-mercaptoalanine equivalent concentration in concentrate to 6-8N, reaching hydrochloric acid equivalent concentration 1.2-2 times of L-beta-mercaptoalanine, agitating at 1-6 degree, lowering temperature to 8-12 degree, laying aside and crystallizing. The crystal grain size is coarse, uniform, transparent, net and diamond, the length is 4-5 mm, and width and thickness are 2-3 mm. It has 5 times re-crystallization and better purity.

Description

The crystallization method of L-cysteine muriate high-purity crystal
Technical field
The present invention relates to the manufacture method of L-cysteine hydrochloride, specifically is the crystallization method that crystallization obtains L-halfcystine high-purity crystal in the cell liquid of electrolysis L-Gelucystine acquisition L-cysteine hydrochloride.
Background technology
The L-cysteine hydrochloride has the effect of the stasis of blood of reducing phlegm mainly as the medicine of bronchitis, radiation injury, and the poisoning that is caused by vinyl cyanide and aromatic acid etc. is had detoxification.Fields such as simultaneously fresh-keeping at bread fermentation, fruit juice, aminoacids complex, enhancing food, day chemical industry and fodder additives are with a wide range of applications.
The L-cysteine hydrochloride mainly exists with the form of monohydrate.L-cysteine hydrochloride molecular formula is C3H7NO2SHClH2O, molecular weight is: 175.61, structural formula is as follows:
Figure A20071002734900031
L-cysteine hydrochloride preparation method adopts L-Gelucystine electrolytic reduction technology substantially, and the L-Gelucystine drops in the hydrochloric acid soln and carries out electrolysis, and after electrolysis finished, the catholyte tank liquor obtained L-cysteine hydrochloride crystal through concentrated, crystallization:
Figure A20071002734900032
This technology is mature on the whole at present, but mother liquor is after repeatedly circulation repeats crystallization after the crystallization, also has only 1: 1.34 by the L-Gelucystine to L-cysteine hydrochloride total conversion rate, differ bigger at 1: 1.46 with theoretical yield, mother liquor repeatedly circulates, and then crystallized product purity and clarity have obvious decline in crystallization, but repeatedly the waste liquid after the crystallization still contains a large amount of callable L-halfcystines, thus people research focus on improving transformation efficiency, the crystallization purifying of L-halfcystine is not appeared in the newspapers yet.Because existing crystallization condition is unreasonable; the L-cysteine hydrochloride crystal that the cell liquid Crystallization Separation obtains is Powdered or tiny needle-like; often be mixed with small amount of impurities in the crystal, therefore need follow-up purifying technique just can obtain high-purity L-cysteine hydrochloride crystal.
Summary of the invention
The object of the present invention is to provide a kind of crystallization method of L-cysteine muriate high-purity crystal, can reduce follow-up recrystallization purifying process thus.
The present invention utilizes electrolysis L-Gelucystine to prepare the catholyte tank liquor of L-halfcystine, after electrolysis finishes, the cell liquid concentrating under reduced pressure, 70~80 ℃ of thickening temperatures, the equivalent concentration 6~8N of L-halfcystine in the concentrated solution after concentrating, the equivalent concentration of regulating hydrochloric acid in the concentrated solution is 1.2~2 times of L-halfcystine, stir cooling down, speed is 1~6 ℃/hour, stops cooling after being cooled to 8~12 ℃ and stirs, left standstill crystallization 6~30 hours, filtration, washing obtain crystal.
Described crystallisation process cooling rate is preferably 2~4 ℃/hour, and leaving standstill crystallization time is 8~12 hours, preferred 5~15 rev/mins of temperature-fall period stirring velocity.。
The L-cysteine hydrochloride crystal size that contains a crystal water that the present invention obtains is thick evenly, 4~5 millimeters of length, 2~3 millimeters of width and thickness, the water chestnut column, glittering and translucent, be difficult for sneaking into impurity in the crystal, mother liquor repeats crystallization through five similarity conditions after the crystallization, crystalline form and purity remain unchanged, and purity reaches more than 99.5%.
Embodiment
Embodiment 1
With hydrochloric acid and pure water compound concentration is 1.6 tons of the hydrochloric acid solns of 2.0N, drops into 350 kilograms of L-Gelucystines, and dissolving is finished the back and added activated carbon by gross weight 1%, stirs decolouring in 40 minutes, filtration, and filtrate pumps into cathode can and carries out cyclic electrolysis.
Electrolytic condition is: voltage 36V, anolyte equivalent concentration is controlled at 2.5N, about 16 hours of electrolysis time.
After electrolysis finishes, filter, filtrate pumps into concentration tank and carries out concentrating under reduced pressure, concentration tank vacuum tightness 0.09MPa, 75 ℃ stirring is concentrated after 10 hours down, check concentrated solution concentration, finish to concentrate check concentration of hydrochloric acid, hydrochloric acid equivalent concentration 10N during L-halfcystine equivalent concentration 8N.Under 10 rev/mins stirring velocity, progressively lower the temperature with 4 ℃/hour cooling rate then, insulation was 1 hour after temperature dropped to 10 ℃.Centrifuging, with the washing of a small amount of frozen water, oven dry obtains epigranular, the water chestnut column crystallization that 4~5 millimeters of length, width and height are 2~3 millimeters, outward appearance is glittering and translucent.Mother liquor concentrating under five identical conditions, crystallization obtain same water chestnut column crystallization.Product is with charging into N2Bag film packing, shading is preserved.The product sampling analysis, detected result is as follows:
ProjectDetected result
Outward appearanceThe translucent crystallization of white, 2~3 millimeters of 4~5 millimeters of length, width, height, water chestnut column
Content 99.7%
The pH value 1.8
Specific rotatory power, [α]D20 +6.2°
Solubility testWater white transparency
Clarity test 98.7%
Chlorine (Cl) 20.02%
Ammonium salt (NH4) 0.01%
Vitriol (SO4) 0.01%
Iron (Fe) 4.0ppm
Heavy metal (Pb) 2.0ppm
Arsenic (As2O3) 0.6ppm
Other amino acidClimb the plate immaculate
Weight loss on drying 10.0%
Ignition residue 0.08%
Embodiment 2
With hydrochloric acid and pure water compound concentration is 1.6 tons of the hydrochloric acid solns of 2.3N, drops into 350 kilograms of L-Gelucystines, and dissolving is finished the back and added activated carbon by gross weight 1%, stirs decolouring in 40 minutes, filtration, and filtrate pumps into cathode can and carries out cyclic electrolysis.
Electrolytic condition is: voltage 36V, anolyte equivalent concentration is controlled at 3.0N, about 16 hours of electrolysis time.
After electrolysis finishes, filter, filtrate pumps into concentration tank and carries out concentrating under reduced pressure, concentration tank vacuum tightness 0.09MPa, 80 ℃ stirring is concentrated after 10 hours down, check concentrated solution concentration, finish during halfcystine equivalent concentration 6N to concentrate, the check concentration of hydrochloric acid, hydrochloric acid equivalent concentration is 8N.Under 10 rev/mins stirring velocity, progressively lower the temperature with 2 ℃/hour cooling rate then, insulation was 1 hour after temperature dropped to 10 ℃.Centrifuging, with the washing of a small amount of frozen water, oven dry obtains epigranular, the water chestnut column crystallization of 4~5 millimeters of length, 2~3 millimeters of width, outward appearance is glittering and translucent.Mother liquor concentrating under five identical conditions, crystallization obtain same water chestnut column crystallization.Product is with charging into N2Bag film packing, shading is preserved.The product sampling analysis, detected result is as follows:
ProjectDetected result
Outward appearanceThe translucent crystallization of white, 2~3 millimeters of 4~5 millimeters of length, width, height, water chestnut column
Content 99.9%
The pH value 1.7
Specific rotatory power, [α]D20 +6.4°
Solubility testWater white transparency
Clarity test 98.9%
Chlorine (Cl) 20.01%
Ammonium salt (NH4) 0.01%
Vitriol (SO4) 0.01%
Iron (Fe) 5.0ppm
Heavy metal (Pb) 2.0ppm
Arsenic (As2O3) 0.7ppm
Other amino acidClimb the plate immaculate
Weight loss on drying 9.4%
Ignition residue 0.05%

Claims (4)

1. the crystallization method of a L-cysteine muriate high-purity crystal, utilize electrolysis L-Gelucystine to prepare the catholyte tank liquor of L-halfcystine, after electrolysis finishes, the cell liquid concentrating under reduced pressure, it is characterized in that, 70~80 ℃ of described thickening temperatures, concentrate the equivalent concentration 6~8N of L-halfcystine in the concentrated solution of back, the equivalent concentration of regulating hydrochloric acid in the concentrated solution is 1.2~2 times of L-halfcystine, stir cooling down, speed is 1~6 ℃/hour, stops cooling after being cooled to 8~12 ℃ and stirs, left standstill crystallization 6~30 hours, filtration, washing obtain crystal.
2. according to the crystallization method of the described L-cysteine muriate high-purity crystal of claim 1, it is characterized in that described crystallisation process cooling rate is 2~4 ℃/hour.
3. according to the crystallization method of the described L-cysteine muriate high-purity crystal of claim 1, it is characterized in that, describedly left standstill crystallization time 8~12 hours.
4. according to the crystallization method of the described L-cysteine muriate high-purity crystal of claim 1, it is characterized in that 5~15 rev/mins of described temperature-fall period stirring velocitys.
CN200710027349.4A2007-03-302007-03-30Method for crystallizing L-cysteine muriate high-purity crystalPendingCN101074480A (en)

Priority Applications (1)

Application NumberPriority DateFiling DateTitle
CN200710027349.4ACN101074480A (en)2007-03-302007-03-30Method for crystallizing L-cysteine muriate high-purity crystal

Applications Claiming Priority (1)

Application NumberPriority DateFiling DateTitle
CN200710027349.4ACN101074480A (en)2007-03-302007-03-30Method for crystallizing L-cysteine muriate high-purity crystal

Publications (1)

Publication NumberPublication Date
CN101074480Atrue CN101074480A (en)2007-11-21

Family

ID=38975742

Family Applications (1)

Application NumberTitlePriority DateFiling Date
CN200710027349.4APendingCN101074480A (en)2007-03-302007-03-30Method for crystallizing L-cysteine muriate high-purity crystal

Country Status (1)

CountryLink
CN (1)CN101074480A (en)

Cited By (6)

* Cited by examiner, † Cited by third party
Publication numberPriority datePublication dateAssigneeTitle
CN110344077A (en)*2019-07-012019-10-18吉林大学A method of by l-cysteine electrochemistry formated n-acetyl-L-cysteine
CN110857474A (en)*2018-08-242020-03-03武汉远大弘元股份有限公司Method for treating L-cysteine hydrochloride monohydrate
CN112251769A (en)*2020-10-102021-01-22武汉本杰明医药股份有限公司Method for synthesizing sulfenyl diacetic acid
US20210054424A1 (en)*2018-01-312021-02-25Cj Cheiljedang CorporationMethod for preparing natural l-cysteine crystals by continuous chromatography
CN116375617A (en)*2022-12-222023-07-04无锡晶海氨基酸股份有限公司Preparation method of pharmaceutical grade L-cysteine hydrochloride
CN116969870A (en)*2023-06-292023-10-31广东人人康药业有限公司Preparation method of acetylcysteine

Cited By (8)

* Cited by examiner, † Cited by third party
Publication numberPriority datePublication dateAssigneeTitle
US20210054424A1 (en)*2018-01-312021-02-25Cj Cheiljedang CorporationMethod for preparing natural l-cysteine crystals by continuous chromatography
US11708591B2 (en)*2018-01-312023-07-25Cj Cheiljedang CorporationMethod for preparing natural L-cysteine crystals by continuous chromatography
CN110857474A (en)*2018-08-242020-03-03武汉远大弘元股份有限公司Method for treating L-cysteine hydrochloride monohydrate
CN110344077A (en)*2019-07-012019-10-18吉林大学A method of by l-cysteine electrochemistry formated n-acetyl-L-cysteine
CN112251769A (en)*2020-10-102021-01-22武汉本杰明医药股份有限公司Method for synthesizing sulfenyl diacetic acid
CN112251769B (en)*2020-10-102021-12-17武汉本杰明医药股份有限公司Method for synthesizing sulfenyl diacetic acid
CN116375617A (en)*2022-12-222023-07-04无锡晶海氨基酸股份有限公司Preparation method of pharmaceutical grade L-cysteine hydrochloride
CN116969870A (en)*2023-06-292023-10-31广东人人康药业有限公司Preparation method of acetylcysteine

Similar Documents

PublicationPublication DateTitle
CN102753514B (en)Process for manufacturing succinic acid
CN101074480A (en)Method for crystallizing L-cysteine muriate high-purity crystal
US20190055186A1 (en)Method for extracting 1,5-pentanediamine from solution system containing 1,5-pentanediamine salt
CN111875490B (en)Preparation method of calcium gluconate
CN117446827A (en) A process for extracting ammonium sulfate from amino acid fermentation wastewater
CN104610385B (en)A kind of process for purification of aminoglucose hydrochloride
CN101078128A (en)Method and device for preparing mannitol and potassium iodate by electrolysis in pairs
CN112813115A (en)Production process of high-purity L-arginine
CN108117054A (en)A kind of method for preparing potassium dihydrogen phosphate coproduction ammonium potassium dihydrogen phosphate
CN1432559A (en)Glutamine extracting process from fermented liquid
CN101103800A (en)Green making technology for monosodium glutanmate
LU500313B1 (en)Process for clean extraction of l-aspartic acid
RU2573935C2 (en)Method of separation and purification of 1,4-diaminobutane from fermentation solution
CN111892498A (en)Method for extracting L-malic acid
CN101235508A (en) Preparation method of high-purity indium sulfate
CN107475526A (en)A kind of method for preparing zinc metal sheet and ammonium chloride using high chlorine smelting ash
CN112778150A (en)Novel crystal form of gamma-aminobutyric acid and preparation method thereof
CN109534369B (en)Membrane integrated lithium chloride preparation equipment and method thereof
CN101103801B (en)Intermittent type glutamic acid crystalloblastic technology
CN103012509B (en)Method of separating and purifying sucrose-6-acetate mother liquor by salt fractionation
CN114195835B (en)New process for preparing coenzyme I injection bulk drug
CN105837460B (en)From the process for cleanly preparing of molasses fermented glutami acid fermentation liquor separation and Extraction glutamic acid
CN110655547A (en)Adenosine extraction method for reducing content of single related impurities
CN1241894C (en)Process for extracting lactic acid from fermentation liquid
CN115927498A (en)Method for improving L-isoleucine fermentation acid production

Legal Events

DateCodeTitleDescription
C06Publication
PB01Publication
C10Entry into substantive examination
SE01Entry into force of request for substantive examination
C02Deemed withdrawal of patent application after publication (patent law 2001)
WD01Invention patent application deemed withdrawn after publication

Open date:20071121


[8]ページ先頭

©2009-2025 Movatter.jp